Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplastic Cells, Circulating 1Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

cabazitaxel 3Trastuzumab 3Cyclophosphamide 2Cetuximab 2Carboplatin 2Aspirin 2ribociclib 1pertuzumab 1eribulin 1Thiotepa 1Taxes 1Stem Cell Transplantation 1Propofol 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Neoadjuvant Therapy 1Liquid Biopsy 1Letrozole 1Ipilimumab 1Histamine H2 Antagonists 1Histamine Antagonists 1Gemcitabine 1Fulvestrant 1Epirubicin 1Docetaxel 1Denosumab 1Circulating Tumor DNA 1Cell-Free Nucleic Acids 1CA-72-4 antigen 1CA-19-9 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplastic Cells, Circulating × Propofol × Clear all
NCT05502458 2022-08-16

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Zhejiang Cancer Hospital

Phase 2 Completed
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡